Creating the West Midlands Childhood Cancer Clinical Cohort
Gathering data to uncover how childhood cancer and its treatment impacts survivors long-term quality of life.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Gathering data to uncover how childhood cancer and its treatment impacts survivors long-term quality of life.
Looking at the differences between healthy brain cells before and after treatment to uncover the mechanisms behind brain-related late effects.
Finding a way to identify patients at risk of brain related side effects from leukaemia treatment, and gathering data to inform future treatment options.
Discovering what causes nerve cells to stop working and die years after a Langerhans cell histiocytosis diagnosis.
Looking at the early stages of leukaemia that develops after treatment for other cancers to find out what changes occur and how to fight it.
Investigating whether giving a medicine before doxorubicin cancer treatment could prevent heart damage.
This project aims to find out more about kidney damage in teenagers and young adults who have been treated for cancer. Dr Nicola Hughes wants to know what puts young people with cancer at risk of kidney damage, and to create helpful information for patients and their families.
Looking into whether survivors of childhood cancer are at risk of severe infections.
Development of a multi-factorial prognostic model to optimise treatment decision making and outcomes in paediatric low-grade glioma